In-vivo Imaging Market Trends

Growth Drivers

Rising Popularity of Minimally Invasive Procedures – Patients are becoming more and more familiar with less invasive procedures as they offer them several advantages such as less pain, and shorter hospital stays. In-vivo imaging is a non-invasive method that is becoming a crucial tool for preclinical research and can be utilized in fundamental biomedical research and clinical medicine.
Growing Geriatric Population- The elderly population is more prone to various age-related diseases such as cancer, and neurodegenerative disorders, which necessitates the usage of In-vivo imaging techniques for diagnosing and monitoring these conditions. Lately, more than 8% of the world's population, are over 65.

Challenges

High Cost of Procedure – In-vivo imaging technologies involve an in-vivo microscope which can easily cost over USD 1 million, which is too expensive in several developing nations. Besides this, cost is one of the main disadvantages of micro-MRI. Systems used for animal imaging, with most systems costing more than USD 1 million.
Data Complexity
Ethical Concerns associated with Involvement of Animals

In-vivo Imaging Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	~6%
Base Year Market Size (2023)	~ USD 3 Billion
Forecast Year Market Size (2036)	~ USD 6 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

Increasing cases of cancer across the globe and the rising trend of precision medicine are the major factors driving the growth of the market.

The market size of In-vivo Imaging is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024 â€“ 2036.

The major players in the market are Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions.

The Micro-MRI segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

In-vivo Imaging Market Trends